Anixa Biosciences Inc (ANIX)

Mar 04, 2026

ANIX SEC FilingsAnixa Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Mar 04, 2026

ANIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 02, 2026

Anixa Biosciences to host 2026 annual meeting of stockholders and provide corporate update highlighting recent clinical and regulatory progress - marketscreener.com

Mar 02, 2026

Mar 02, 2026

Anixa Biosciences To Host 2026 Annual Meeting Of Stockholders And Provide Corporate Update Highlighting Recent Clinical And Regulatory Progress - TradingView

Mar 02, 2026

Mar 02, 2026

Anixa to outline ovarian CAR-T survival, breast cancer vaccine data - Stock Titan

Mar 02, 2026

Feb 24, 2026

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Feb 24, 2026

Feb 23, 2026

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat - Investing News Network

Feb 23, 2026

Feb 23, 2026

Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote - GuruFocus

Feb 23, 2026

Feb 21, 2026

Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic - Intellectia AI

Feb 21, 2026

Feb 20, 2026

Can Anixa Biosciences Inc. stock double in the next yearJuly 2025 Weekly Recap & Long Hold Capital Preservation Plans - mfd.ru

Feb 20, 2026

Feb 19, 2026

ANIX: Robust 2025 Milestones Set the Stage for a Pivotal 2026 - Smartkarma

Feb 19, 2026

Feb 18, 2026

Anixa Biosciences to Present at the iAccess Alpha Virtual Best I - GuruFocus

Feb 18, 2026

Feb 17, 2026

Whale Trades: Will Anixa Biosciences Inc. stock reach all time highs in 2025 - mfd.ru

Feb 17, 2026

Feb 14, 2026

Will Anixa Biosciences Inc. stock reach all time highs in 20252025 Price Targets & Community Consensus Trade Alerts - mfd.ru

Feb 14, 2026

Feb 14, 2026

Why Anixa Biosciences Inc. stock is seen as undervalued2025 Fundamental Recap & Reliable Breakout Forecasts - mfd.ru

Feb 14, 2026

Feb 13, 2026

Anixa Biosciences Updates Ovarian Cancer CAR-T Trial Outcomes - Intellectia AI

Feb 13, 2026

Feb 13, 2026

Aug Momentum: Can Anixa Biosciences Inc maintain its current growth rate2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn

Feb 13, 2026

Feb 11, 2026

Can Anixa Biosciences Inc. keep up with sector leadersJuly 2025 Sentiment & Risk Managed Investment Entry Signals - mfd.ru

Feb 11, 2026

Feb 10, 2026

Anixa Biosciences CEO Calls 2026 “Pivotal” as Breast Cancer Vaccine, Ovarian CAR-T Advance - MarketBeat

Feb 10, 2026

Feb 10, 2026

ANIX: Pivotal data from advanced cancer trials and fiscal discipline set the stage for a transformative 2026 - TradingView

Feb 10, 2026

Feb 10, 2026

Anixa reports promising survival data in ovarian cancer CAR-T trial - Investing.com Australia

Feb 10, 2026

Feb 09, 2026

Anixa Biosciences Reports Encouraging Patient Survival Observati - GuruFocus

Feb 09, 2026

Feb 09, 2026

Why Anixa Biosciences Inc. stock is trending among retail tradersWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru

Feb 09, 2026

Feb 09, 2026

Anixa Biosciences (ANIX) Reports Positive Data in Ovarian Cancer CAR-T Trial - GuruFocus

Feb 09, 2026

Feb 09, 2026

Anixa Advances Ovarian Cancer CAR-T With Higher Dosing - TipRanks

Feb 09, 2026

Feb 09, 2026

Anixa Biosciences reports encouraging patient survival observations in ovarian cancer CAR-T trial - marketscreener.com

Feb 09, 2026

Feb 09, 2026

Anixa Biosciences Reports Encouraging Patient Survival Observations In Ovarian Cancer Car-T Trial - TradingView

Feb 09, 2026

Feb 09, 2026

ANIX: Major dose escalation approved after strong survival and safety data in ovarian cancer CAR-T trial - TradingView

Feb 09, 2026

Feb 09, 2026

Anixa Biosciences Reports Encouraging Data in Ovarian Cancer CAR-T Trial - TradingView

Feb 09, 2026

Feb 09, 2026

Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation - PR Newswire

Feb 09, 2026

Feb 09, 2026

EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues - Sahm

Feb 09, 2026

Feb 08, 2026

Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation - Yahoo Finance

Feb 08, 2026

Feb 07, 2026

Anixa Biosciences (NASDAQ:ANIX) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Feb 07, 2026

Feb 04, 2026

ANIX: Analyst Maintains "Buy" Rating and $10 Price Target | ANIX Stock News - GuruFocus

Feb 04, 2026

Feb 04, 2026

D. Boral Capital Reiterates "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat

Feb 04, 2026

Feb 03, 2026

Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization - BioSpace

Feb 03, 2026

Feb 02, 2026

Anixa Biosciences Secures United States Adopted Names Council Ap - GuruFocus

Feb 02, 2026

Feb 02, 2026

Anixa Biosciences (ANIX) CAR-T Therapy Receives USAN Approval - GuruFocus

Feb 02, 2026

Feb 01, 2026

Market Recap: Can Anixa Biosciences Inc keep up with sector leadersJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn

Feb 01, 2026

Jan 30, 2026

Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Jan 30, 2026

Jan 30, 2026

Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus

Jan 30, 2026

Jan 29, 2026

Anixa Biosciences (NASDAQ:ANIX) Director Arnold Baskies Acquires 10,000 Shares - MarketBeat

Jan 29, 2026

Jan 29, 2026

Anixa Biosciences director Baskies buys $30,400 in stock By Investing.com - Investing.com UK

Jan 29, 2026

Jan 29, 2026

Anixa Biosciences director Baskies buys $30,400 in stock - Investing.com

Jan 29, 2026

Jan 28, 2026

Anixa Biosciences receives Mexican patent for breast cancer vaccine By Investing.com - Investing.com Australia

Jan 28, 2026